Psychiatric Presentation of Hashimoto's Encephalopathy
Manuel Arrojo, MD,
Maria M. Perez-Rodriguez, MD,
Márcia Mota, MD,
Ricardo Moreira, MD,
Ana Azevedo, MD,
Ana Oliveira, MD,
Pedro Abreu, MD,
Paula Marques, MD,
Alzira Silva, MD,
Jorge G. Pereira, MD,
A. Pacheco Palha, MD and
Enrique Baca-Garcia, MD
From the Departments of Psychiatry (M.A., M.M., R.M., A.S., A.P.P.), Internal Medicine (A.A., P.M.), Nuclear Medicine (A.O., J.G.P.), Neurology (P.A.), Hospital S. João, Alameda Prof Hernani Monteiro, Porto, Portugal; the Department of Psychiatry (M.M.P.-R.), Ramón y Cajal University Hospital, Madrid, Spain; and the Department of Neuroscience (E.B.-G.), Columbia University Medical Center, New York, NY.

View larger version (140K):
[in this window]
[in a new window]
|
Figure 1. Transverse plane 99mTc-HMPAO brain single-photon emission-computed tomography images show decreased radiotracer uptake in the frontal, left temporoparietal, and left posterior parietal regions, consistent with decreased perfusion in those areas.
|
|
Copyright © 2007 by the American Psychosomatic Society